Archive | Cost Curve

Cost Curve
Archive
Page 20

Archive

CMS is Done Hearing from Patients on the IRA. But Did They Listen?

And the battle against copay accumulators appears to be far from over

Brian Reid

A New Analysis Questions the IRA's Orphan-Drug Exemption (Without Talking Tradeoffs)

Plus some datapoints on launch prices

Brian Reid

New PostBoth Novo and the WaPo Define the Obesity-Med Challenge Well. Defining the Solutions is Another Matter.

Plus learning from the Thanksgiving table

Brian Reid

Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say.

And a brief list of the folks I'm thankful for

Brian Reid

A Quick Look At Everything I Missed While I Was Gone

And, yup: the Canadian Rockies are gorgeous

Brian Reid

Three New Research Pieces to Boost Understanding of Pharma Industry Nuances

Plus a perfect, tragic example that explains why Americans are deeply skeptical of insurers

Brian Reid

The Medicaid Best-Price Rule Is Having a Moment

And some thoughts about PBM press releases and evil genies

Brian Reid

Strong Data Showing Heart Benefits to Obesity Meds Raises the Big Question: Whither Medicare

Plus some worthwhile comments from AZ's Soriot on the company's IRA approach

Brian Reid

There Are 1,600 Medicines in Development for Cancer, Proving Incentives Matter

Plus Optum is making insulins more accessible

Brian Reid

Looking Under the Hood at the Pricing Approach for the New Zepbound Obesity Med

And a 340B decision is elevating the definition of 'patient'

Brian Reid

A Great WSJ Story Looks At the False Promise of Drugs with Two Prices

And there's a new AARP poll coming on the importance of drug prices on voters

Brian Reid

Rich Hospitals Using 340B to Get Even Richer, According to a New Analysis

Plus lots of thinking about the future of gene therapy today

Brian Reid

16 17 18 19 20 21 22 23